Elsevier / MEDai Enhances Real-Time Clinical Surveillance System for Hospitals

Pinpoint Review(R) Enhancements Allow Hospitals and Clinicians to Provide Safer, More Efficient and Less Costly Care

ORLANDO, Florida, February 14, 2011 - Elsevier / MEDai, a leading provider of advanced clinical analytic
healthcare solutions, announced today the launch of the latest version of
Pinpoint Review(R), its real-time, clinical surveillance system for
hospitals. The new version will feature an expanded set of clinical watch
triggers, expanded core measure alerts and three new predictions: ICU
Admission Prediction, Length of Stay Prediction and Mortality Prediction.

"Hospitals are facing an enormous amount of pressure to provide better,
safer care with fewer complications while managing costs," said Swati Abbott,
President of Elsevier / MEDai. "Elsevier / MEDai has enhanced its predictive
analytics product to continuously give hospitals and clinicians the most
up-to-date tools they need to lower mortality rates and healthcare costs,
provide a higher quality of care, increase patient safety and maintain
regulatory compliance."

Pinpoint Review generates predictions for acute-care patients, focusing
on the likelihood of a patient developing a complication, contracting a
healthcare-acquired infection or being readmitted within 30 days of
discharge, while patients are still in the hospital and there is time to
adjust care to avoid a negative outcome.

With the expansion of Pinpoint Review's new predictions, care givers are
able to enhance their efforts in proactive care management. Pinpoint Review
unlocks the power of clinical and administrative hospital data by utilizing
predictive technologies to turn data into actionable information. Empowering
today's hospitals with the ability to predict whether or not a patient will
be admitted to the ICU or higher intensity care unit, a predicted length of
hospital stay or patient expiration goes a long way in driving down the cost
of care and brings a proactive approach to quality improvement.

Pinpoint Review addresses the increasing pressure on hospitals from
entities such as the Agency for Healthcare Research and Quality and the Joint
Commission on Accreditation of Healthcare Organizations to deliver a higher
quality of care and fewer medical errors. Pinpoint Review alerts care
providers to patients at risk for developing several of the conditions that
the Centers for Medicare and Medicaid Services (CMS) no longer reimburse.

Additional Elsevier / MEDai tools include Pinpoint Quality(R) and
Pinpoint Compliance(R). Pinpoint Quality provides robust retrospective
outcomes analysis that helps hospitals and physicians quickly identify areas
for improvement, making it possible for clinicians to improve performance,
outcomes, patient satisfaction, efficiency and cost savings by understanding
the drivers of the negative outcomes and allowing them to compare their
performance against national standard benchmarks. Pinpoint Compliance(R)
provides a simple, time-saving Web-based solution for organizations to
collect, report and submit data to the Joint Commission, CMS, and other
regulatory reporting agencies, while participating in initiatives related to
accreditation, quality improvement and compliance.

About Elsevier / MEDai

Elsevier / MEDai, Inc., is a subsidiary of Elsevier, a world-leading
publisher of more than 2,000 scientific, technical and medical information
products and services. Elsevier / MEDai offers award-winning solutions for
the improvement of healthcare delivery. Utilizing cutting-edge technology,
payors and care management organizations are able to predict patients at
risk, identify cost drivers for their high-risk population, forecast future
health plan costs, evaluate patient patterns over time and improve outcomes.
For more information on Elsevier / MEDai, visit www.medai.com.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com) and Cell
(www.cell.com), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect (www.sciencedirect.com), SciVerse Scopus
(www.scopus.com), Reaxys (www.reaxys.com), MD Consult
(www.mdconsult.com) and Nursing Consult (www.nursingconsult.com
), which enhance the productivity of science and health professionals, and
the SciVal suite (www.scival.com) and Elsevier / MEDai's Pinpoint Review
(www.medai.com), which help research and health care institutions
deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    For more information, please visit www.medai.com or call
    800-446-3324.

    Media Contact
    Tom Reller
    VP, Corporate Relations, Elsevier
    T.Reller@elsevier.com
    +1-215-239-3508

For more information, please visit www.medai.com or call 800-446-3324; Media Contact: Tom Reller, VP, Corporate Relations, Elsevier, T.Reller at elsevier.com, +1-215-239-3508